Ms. Gauthier has served as Senior Vice President, Regional Head for Australia, Canada and the United Kingdom at Moderna since 2025, where she leads end-to-end strategy and operations across biomanufacturing, national health security partnerships, R&D collaborations and commercialization of in-market and pipeline products. She oversees significant regional investment, regional P&L, and approximately 500 employees across direct and matrixed teams.

Previously, Ms. Gauthier held other senior roles at Moderna, including General Manager of Moderna Canada, where she built the Canadian affiliate from inception, supported delivery of more than 50 million COVID-19 vaccine doses, and helped secure a landmark biomanufacturing partnership with the Government of Canada. She also led the creation of Moderna’s global rare disease business and defining its global strategy, operating model and go-to-market approach. Before Moderna, Ms. Gauthier held senior leadership roles at GSK across vaccines, specialty care, general medicines, market access and government affairs. Earlier in her career, she practiced law at McCarthy Tétrault LLP.

Ms. Gauthier serves on the boards of AdMare BioInnovations (Canadian private company). She holds an MBA from HEC Montréal and an LL.B. from the Université de Sherbrooke, with executive education from Harvard Business School (negotiation) and IMD (leadership).